TVB 2640 for Resectable Colon Cancer Other Resectable Cancers; a Window Trial.
NCT02980029
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
23
Enrollment
OTHER
Sponsor class
Stopped
Study was terminated by the PRMC for low accrual
Conditions
Colon Cancer
Interventions
DRUG:
TVB-2640
OTHER:
Placebo
Sponsor
Mark Evers
Collaborators
[object Object]